BioSig Tech Inspired a Bioelectronic Medicine Alliance

Recently, BioSig Tech announced that the company supported the launch of the Alliance for Advancing Bioelectronic Medicine (AABM), an independent network of professionals united to support bioelectronic medicine. BioSig Tech is a Connecticut-headquartered medical technology company, developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals.

BioSig Tech first product is named ‘PURE EP System’. It is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

So, how did this Alliance occur in the first place?

Apparently, the alliance grew out of an invitation-only roundtable and working group that BioSig organized earlier this year, at which a distinguished group of researchers, entrepreneurs, and healthcare experts agreed on the need for a collaborative effort to create a shared vision for bioelectronic medicine.

The main aim of the Alliance for Advancing Bioelectronic Medicine is to play a unique convening role, mobilizing patients, physicians, and other stakeholders to advocate for the field, and increasing awareness among audiences that are important for the field’s growth, including policymakers, investors, media, and the general public. The steering committee of the alliance includes experts with experience at the Mayo Clinic, the Heart Rhythm Society, the European Heart Rhythm Association, The Feinstein Institute, RAND Corporation, Battelle, Imperial College London, and Sheba Medical Center.

As Kenneth L Londoner, Founder, CEO, and Chairman of BioSig Technologies recently said in a statement, the entire company is looking forward to work with the alliance and its members to articulate the value of bioelectronic medicine, catalyze meaningful cross-sector collaboration, and engage new audiences. These goals are vital to driving the field’s progress and impact on patients’ lives across disease areas.

According to Dr. Hein Heidbuchel, a founding member of AABM and Professor and Chair of Cardiology, Anwerp University and President of the European Heart Rhythm Association, BioSig’s leadership and support have helped to connect bioelectronic medicine experts from diverse areas of the field, which has led to forming the Alliance for Advancing Bioelectronic Medicine.